236,497 Shares in Omega Healthcare Investors, Inc. $OHI Bought by Fideuram Intesa Sanpaolo Private Banking S.P.A.

Fideuram Intesa Sanpaolo Private Banking S.P.A. acquired a new position in Omega Healthcare Investors, Inc. (NYSE:OHI) in the 4th quarter, Holdings Channel reports. The institutional investor acquired 236,497 shares of the real estate investment trust’s stock, valued at approximately $10,486,000.

Several other large investors also recently modified their holdings of the company. Royal Bank of Canada lifted its position in Omega Healthcare Investors by 29.4% during the first quarter. Royal Bank of Canada now owns 144,339 shares of the real estate investment trust’s stock valued at $5,496,000 after purchasing an additional 32,798 shares in the last quarter. Focus Partners Wealth lifted its position in Omega Healthcare Investors by 3.1% during the first quarter. Focus Partners Wealth now owns 19,862 shares of the real estate investment trust’s stock valued at $756,000 after purchasing an additional 597 shares in the last quarter. Sivia Capital Partners LLC purchased a new position in Omega Healthcare Investors during the second quarter valued at $257,000. Guggenheim Capital LLC lifted its position in Omega Healthcare Investors by 1.0% during the second quarter. Guggenheim Capital LLC now owns 29,398 shares of the real estate investment trust’s stock valued at $1,077,000 after purchasing an additional 280 shares in the last quarter. Finally, First Trust Advisors LP lifted its position in Omega Healthcare Investors by 32.8% during the second quarter. First Trust Advisors LP now owns 193,099 shares of the real estate investment trust’s stock valued at $7,077,000 after purchasing an additional 47,649 shares in the last quarter. Institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Price Performance

Shares of Omega Healthcare Investors stock opened at $48.73 on Wednesday. The stock’s 50-day simple moving average is $46.34 and its 200-day simple moving average is $45.40. Omega Healthcare Investors, Inc. has a 52 week low of $35.70 and a 52 week high of $49.14. The company has a market capitalization of $14.51 billion, a price-to-earnings ratio of 23.54, a PEG ratio of 2.16 and a beta of 0.59. The company has a quick ratio of 5.32, a current ratio of 5.32 and a debt-to-equity ratio of 0.81.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings data on Tuesday, April 28th. The real estate investment trust reported $0.47 EPS for the quarter, missing the consensus estimate of $0.49 by ($0.02). Omega Healthcare Investors had a net margin of 51.14% and a return on equity of 11.86%. The business had revenue of $322.96 million during the quarter, compared to analysts’ expectations of $264.07 million. During the same quarter in the previous year, the firm earned $0.75 earnings per share. Omega Healthcare Investors’s revenue was up 16.7% on a year-over-year basis. Omega Healthcare Investors has set its FY 2026 guidance at 3.190-3.250 EPS. As a group, analysts expect that Omega Healthcare Investors, Inc. will post 3.06 earnings per share for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, May 15th. Investors of record on Monday, May 4th were given a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a dividend yield of 5.5%. The ex-dividend date was Monday, May 4th. Omega Healthcare Investors’s payout ratio is currently 129.47%.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the company. UBS Group lifted their target price on Omega Healthcare Investors from $52.00 to $54.00 and gave the company a “buy” rating in a research report on Wednesday, May 13th. Bank of America reiterated an “underperform” rating and set a $46.00 target price (down from $52.00) on shares of Omega Healthcare Investors in a research report on Tuesday, April 14th. Wells Fargo & Company lifted their target price on Omega Healthcare Investors from $45.00 to $47.00 and gave the company an “equal weight” rating in a research report on Thursday, March 26th. Scotiabank lifted their target price on Omega Healthcare Investors from $45.00 to $48.00 and gave the company a “sector perform” rating in a research report on Monday, March 2nd. Finally, BMO Capital Markets reiterated a “market perform” rating and set a $52.00 target price on shares of Omega Healthcare Investors in a research report on Monday, May 4th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $48.83.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.